Matthew Rees

34PUBLICATIONS

476CO-AUTHORS

Molecular targetsCentral nervous systemPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Characterisation of biological macromolecules

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (34)

Sort by Publication Date:

|May 22, 2026

Genetic Drivers of Sensitivity or Resistance to RAS(ON) Multi-Selective Inhibitors in NRAS-Mutated Melanoma.

|May 06, 2026

Expanding the human proteome with microproteins and peptideins.

|Oct 27, 2025

PI3Kα Inhibitor and Degrader Inavolisib Can Co-opt FGFR2 to Enhance Responses in Patients with PIK3CA-Mutated Solid Tumors and in Preclinical Models.

Dejan Juric, Kyung Song, Radia M Johnson

|Oct 03, 2025

Targeting histone H2B acetylated enhanceosomes via p300/CBP degradation in prostate cancer.

Jie Luo, Zhixiang Chen, Yuanyuan Qiao

|Sep 13, 2025

CF10 Displayed Improved Activity Relative to 5-FU in a Mouse CRLM Model Under Conditions of Physiological Folate.

Charles Chidi Okechukwu, Xue Ma, Wencheng Li

|Sep 03, 2025

An allele-agnostic mutant-KRAS inhibitor suppresses tumor maintenance signals and reprograms tumor immunity in pancreatic cancer.

Kathleen M McAndrews, Francesca Paradiso, Clint A Stalnecker

Pageof 6

Frequent Collaborators

26 joint publications

Jennifer Roth

21 joint publications

Melissa Ronan

Andrew S Boghossian

Julien Dilly

Jacqueline A M Smith

David Wildes

Andrew J Aguirre

Channing J Der

Andrew L Hong

Clint A Stalnecker

Frequent Collaborators

26 joint publications

Jennifer Roth

21 joint publications

Melissa Ronan

7 joint publications

Andrew S Boghossian

4 joint publications

Julien Dilly